4//SEC Filing
Louks Ronald Allen 4
Accession 0000899243-21-035503
CIK 0001566469other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 9:16 PM ET
Size
20.6 KB
Accession
0000899243-21-035503
Insider Transaction Report
Form 4
Louks Ronald Allen
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-09-08$0.55/sh+4,700$2,585→ 230,557 total - Sale
Common Stock
2021-09-08$2.25/sh−4,700$10,583→ 225,857 total - Exercise/Conversion
Stock Option (right to buy)
2021-09-07−16,613→ 531,882 totalExercise: $0.55Exp: 2029-08-12→ Common Stock (16,613 underlying) - Sale
Common Stock
2021-09-07$2.30/sh−16,613$38,148→ 225,857 total - Exercise/Conversion
Common Stock
2021-09-03$0.55/sh+1,505$828→ 227,362 total - Sale
Common Stock
2021-09-03$2.34/sh−1,505$3,515→ 225,857 total - Exercise/Conversion
Common Stock
2021-09-07$0.55/sh+16,613$9,139→ 242,470 total - Exercise/Conversion
Stock Option (right to buy)
2021-09-03−1,505→ 548,495 totalExercise: $0.55Exp: 2029-08-12→ Common Stock (1,505 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-09-08−4,700→ 527,182 totalExercise: $0.55Exp: 2029-08-12→ Common Stock (4,700 underlying)
Footnotes (4)
- [F1]Represents the weighted average share price of an aggregate total of 1,505 shares sold in the price range of $2.31 to $2.38 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 16,613 shares sold in the price range of $2.25 to $2.32 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 4,700 shares sold in the price range of $2.25 to $2.26 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Subject to the reporting person continuing as a service provider, the shares subject to the option shall vest as follows, fifty percent (50%) of the shares subject to the option shall vest on the one (1) year anniversary from the date of grant, and twenty-five percent (25%) of the remaining shares subject to the option shall vest annually thereafter, so that the option is fully vested on the three (3) year anniversary date.
Documents
Issuer
NantHealth, Inc.
CIK 0001566469
Entity typeother
Related Parties
1- filerCIK 0001706849
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 9:16 PM ET
- Size
- 20.6 KB